Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Therapy-Related Myeloid Neoplasm: A Study from the Chronic Malignancies Working Party of the EBMT

Blood (2019) 134 (Supplement_1): 45.

https://doi.org/10.1182/blood-2019-124765

Published: 2019

Journal Articles

Allogeneic Hematopoietic Stem-Cell Transplantation for Patients with Richter's Syndrome:the SFGM-TC Experience

Blood (2018) 132 (Supplement 1): 3457.

https://doi.org/10.1182/blood-2018-99-117904

Published: 2018

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients with Acute Myeloid Leukemia: Analysis of the Francophone Society for Stem Cell Transplantation and Cell Therapy

Regis Peffault De Latour, Matthieu Resche-Rigon, MD PhD, Didier Blaise, Johan Maertens, MD, Patrice Ceballos, MD, Patrice Chevallier, MD, Edouard Forcade, MD, Anne Huynh, MD, Pierre Simon Rohrlich, Helene Labussiere-Wallet, MD, Jacques-Olivier Bay, MD PhD, Yves Chalandon, MD PhD, Gerard Socie, MD PhD, Marie Thérèse Rubio, MD

Blood (2018) 132 (Supplement 1): 3447.

https://doi.org/10.1182/blood-2018-99-111710

Published: 2018

Journal Articles

The Impact of Cytogenetics on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia: A Survey from the Acute Leukemia Working Party (ALWP) of EBMT

Monica Poiani, Myriam Labopin, MD, Dietrich W. Beelen, Johanna Tischer, Jürgen Finke, MD, Arne Brecht, MD, Edouard Forcade, MD, Arnold Ganser, MD, Jakob R. Passweg, MDMS, Helene Labussiere-Wallet, MD, Ibrahim Yakoub-Agha, MD PhD, Kerstin Schäfer-Eckart, MD, Nicolaus Kroeger, MD, Bruno Lioure, MD, Annalisa Ruggeri, MD, Jordi Esteve, MD PhD, Arnon Nagler, MD, Mohamad Mohty, MD PhD

Blood (2018) 132 (Supplement 1): 4639.

https://doi.org/10.1182/blood-2018-99-113799

Published: 2018

Journal Articles

Long-Term Outcome of Patients Receiving Extracorporeal Photopheresis for Acute and Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies: Results from an Observational Study on 106 Patients

Mauricette Michallet, MD PhD, Mohamad Sobh, Alexandre Deloire, CRA, Daniela Revesz, MD, Youcef Chelgoum, MD, Mohamed El-Hamri, CRA, Fiorenza Barraco, MD, Helene Labussiere-Wallet, MD, Franck Emmanuel Nicolini, MD PhD, Olivier Hequet, MD

Blood (2017) 130 (Supplement 1): 4504.

https://doi.org/10.1182/blood.V130.Suppl_1.4504.4504

Published: 2017

Journal Articles

Impact of Body Mass Index on Outcome in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Imatinib in First-Line

Gaelle Fossard, MD, Vincent Alcazer, MD, Marie Balsat, MD, Helene Labussiere-Wallet, MD, Stephane Morisset, Stat, Mohamad Sobh, Isabelle Tigaud, MD, Pierre Sujobert, MD PhD, Mauricette Michallet, MD PhD, Franck Emmanuel Nicolini, MD PhD

Blood (2017) 130 (Supplement 1): 2900.

https://doi.org/10.1182/blood.V130.Suppl_1.2900.2900

Published: 2017

Journal Articles

A Composite Event-Free Survival End Point to Evaluate Outcome after Allogeneic Transplantation for Severe Aplastic Anemia: A Study on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Raynier Devillier, MD PhD, Hélène Labussière-Wallet, MD, Laurence Clément, MD, Ibrahim Yakoubagha, Jacques-Olivier Bay, MD PhD, Virginie Gandemer, MD PhD, Marie t Rubio, MD PhD, Anne Sirvent, MD, Patrice Chevallier, MD PhD, Thierry Derevel, Sebastien Maury, MD PhD, Gerard Socie, MD PhD, Regis Peffault de Latour, MD PhD

Blood (2016) 128 (22): 2674.

https://doi.org/10.1182/blood.V128.22.2674.2674

Published: 2016

Journal Articles

Reactive Hemophagocytic Syndrome after Hematopoietic Stem Cell Transplantation: A Multicenter Retrospective Study on Behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

Federico Simonetta, MD PhD, Hélène Labussière-Wallet, MD, Maciej J Machaczka, MD, Flore Sicre de Fontbrune, MD, Michael Medinger, MD, Sylvain Chantepie, MD, Tony Marchand, MD, Stavroula Masouridi-Levrat, MD, Marie-Thérèse Rubio, MD PhD, Oumedaly Reman, MD, Nathalie Dhedin, MD, Loic Fouillard, MD, Olivier Lambotte, MD PhD, Lionel Galicier, MD, Paul Coppo, MD PhD, Jakob Passweg, MD, Ibrahim Yakoub-Agha, MD PhD, Regis Peffault De Latour, MD PhD, Yves Chalandon, MD

Blood (2016) 128 (22): 4617.

https://doi.org/10.1182/blood.V128.22.4617.4617

Published: 2016

Journal Articles

First Results of a Prospective Study on Erythropoietin Biosimilar (Epoetin zeta) Use in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Mauricette Michallet, MD PhD, Mohamad Sobh, PharmD, Jeremy Monfray, CRA, Hélène Labussière-wallet, MD, Marie Balsat, MD, Caroline Lejeune, MD, Sophie Ducastelle-Leprêtre, MD, Fiorenza Barraco, MD, Xavier Thomas, Franck E. Nicolini, MD PhD

Blood (2015) 126 (23): 4477.

https://doi.org/10.1182/blood.V126.23.4477.4477

Published: 2015

Journal Articles

Survey of Serum Aspergillus Antigen in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia or Allogeneic Hematopoietic Stem Cell Transplantation: Role in Predicting Invasive Aspergillosis and in Modifying the Therapeutic Strategy

Van Hung Tran, PhD, Florence Persat, MD, Sophie Gardes, MD, Jeremy Monfray, CRA, Sophie Ducastelle-Leprêtre, MD, Damien Dupont, Mohamad Sobh, PharmD, Fiorenza Barraco, MD, Hélène Labussière-Wallet, MD, Xavier Thomas, Franck E. Nicolini, MD PhD, Caroline Lejeune, MD, Marie Balsat, MD, René Ecochard, MD PhD, Mauricette Michallet, MD PhD

Blood (2015) 126 (23): 3428.

https://doi.org/10.1182/blood.V126.23.3428.3428

Published: 2015

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Peripheral Blood or Bone Marrow Donors: The Impact of HLA Matching Including HLA-DPB1 Allele in a Multivariable Risk Model

Mauricette Michallet, MD PhD, Mohamad Sobh, PharmD, Hélène Labussière-wallet, MD, Marie Balsat, MD, Caroline Lejeune, MD, Sophie Ducastelle-Leprêtre, MD, Xavier Thomas, Catherine Giannoli, Philippe Moskovtchenko, Tech., Fiorenza Barraco, MD, Franck E. Nicolini, MD PhD, Valérie Dubois, MD

Blood (2015) 126 (23): 3213.

https://doi.org/10.1182/blood.V126.23.3213.3213

Published: 2015

Journal Articles

Optimizing the Outcomes of Allogeneic Hematopoietic Stem Cell (HSC) Transplantation for Hematological Malignancies: The Perfect Combination of Conditioning Regimen, Disease Stage and Type of HSC Donor

Mauricette Michallet, MD PhD, Mohamad Sobh, PharmD, Hélène Labussière-wallet, MD, Marie Balsat, MD, Caroline Lejeune, MD, Sophie Ducastelle-Leprêtre, MD, Fiorenza Barraco, MD, Xavier Thomas, Franck E. Nicolini, MD PhD

Blood (2015) 126 (23): 4324.

https://doi.org/10.1182/blood.V126.23.4324.4324

Published: 2015

Journal Articles

Brentuximab Vedotin Followed By Allogeneic Stem-Cell Transplantation for Patients with CD30 Anaplastic or T Cell Non Hodgkin Lymphomas: A Study on Behalf of the SFGM-TC.

Sylvain Garciaz, MD, Michael Loschi, MD, Adele de Masson, MD, Sylvie François, MD, Cecile Tomowiak, MD, Nathalie Fegueux, MD, Hélène Labussière-Wallet, MD, David Sibon, MD, Ophelie Cassuto, MD, Cecile Borel, MD, Jérôme Cornillon, MD, Stanislas Nibumona, MD, Amandine Charbonnier, MD, Pauline Brice, MD, Gerard Socie, Didier Blaise, MD PhD, Regis Peffault de la Tour, MD PhD, Flore Sicre de Fontbrune, MD

Blood (2015) 126 (23): 4377.

https://doi.org/10.1182/blood.V126.23.4377.4377

Published: 2015

Journal Articles

Mixed Chimerism at Three Months after Allogeneic Hematopoietic Stem Cell Transplantation Is a Significant Predictor of Disease Relapse in High-Risk Acute Myeloid Leukemia Patients in First Complete Remission

Mauricette Michallet, MD PhD, Mohamad Sobh, PharmD, Hélène Labussière-wallet, MD, Marie Balsat, MD, Caroline Lejeune, MD, Isabelle Mollet, Tech., Philippe Moskovtchenko, Tech., Xavier Thomas, Fiorenza Barraco, MD, Valérie Mialou, Tech., Valérie Dubois, MD, Franck E. Nicolini, MD PhD

Blood (2015) 126 (23): 2577.

https://doi.org/10.1182/blood.V126.23.2577.2577

Published: 2015

Journal Articles

Very Long-Term Follow-up (> 80 months) of Imatinib (IM) First-Line for Chronic Phase (CP) CML Patients

Franck E. Nicolini, MD PhD, Marie Balsat, MD, Maud Lekieffre, MD, Vincent Alcazer, MD, Hélène Labussière-wallet, MD, Sarah Huet, PharmD, PhD, Sandrine Hayette, Stéphanie Dulucq, PharmD, PhD, Stéphane Morisset, Stat, Jeremy Ruby, CRA, Isabelle Tigaud, MD, Marie-Pierre Fort, CRA, Mael Heiblig, MD, Rémi Chapelon, CRA, Madeleine Etienne, CRA, Mohamad Sobh, PharmD, Francois-Xavier Mahon, MD PhD Professor, Mauricette Michallet, MD PhD, Gabriel Etienne, MD PhD

Blood (2015) 126 (23): 2774.

https://doi.org/10.1182/blood.V126.23.2774.2774

Published: 2015

Journal Articles

Primary Failure of Platelet Recovery Is the Foremost Prognostic Factor after Allogeneic Stem Cell Transplantation Following Myeloablative Conditioning for Myelodysplastic Syndrome: A Study from the SFGM-TC

Jordan Gauthier, MDMSc, Gandhi Damaj, MD PhD, Marie Robin, MD PhD, Nathalie Contentin, MD, Yves Beguin, MD PhD, Eric Deconinck, MD PhD, Anne Huynh, MD, Stephane Vigouroux, Patrice Chevalier, Hélène Labussière-Wallet, MD, Felipe Suarez, MD PhD, Mohamad Mohty, MD, Ibrahim Yakoub-Agha, MD PhD

Blood (2015) 126 (23): 5444.

https://doi.org/10.1182/blood.V126.23.5444.5444

Published: 2015

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients in First Complete Remission: Significant Impact of the Interval Between Diagnosis and Transplantation on Different Outcomes

Stéphanie Ducreux, PharmD, Mohamad Sobh, PharmD, Stéphane Morisset, Stat, Marie Balsat, MD, Xavier Thomas, Caroline Lejeune, MD, Sophie Ducastelle-Leprêtre, MD, Fiorenza Barraco, MD, Hélène Labussière-wallet, MD, Franck E. Nicolini, MD PhD, Mauricette Michallet, MD PhD, Valérie Dubois, MD

Blood (2015) 126 (23): 5517.

https://doi.org/10.1182/blood.V126.23.5517.5517

Published: 2015

Journal Articles

Impact of Early Post-Transplant Complications on Survival of Patients with Myelodysplastic Syndrome Undergoing Allo-SCT Following Reduced Intensity Conditioning: An SFGM-TC Study

Alexis Caulier, Jordan Gauthier, MDMSc, Marie Robin, MD PhD, Patrice Chevalier, Yves Beguin, MD PhD, Hélène Labussière-Wallet, MD, Stephane Vigouroux, Jean-Yves Cahn, MD, Stéphanie Nguyen, Felipe Suarez, MD PhD, Anne Huynh, MD, Norbert Ifrah, MD, Mohamad Mohty, MD, Eric Deconinck, MD PhD, Gandhi Damaj, MD PhD, Ibrahim Yakoub-Agha, MD PhD

Blood (2015) 126 (23): 1922.

https://doi.org/10.1182/blood.V126.23.1922.1922

Published: 2015

Journal Articles

Impact of Initial Body Mass Index (BMI) on Survival Outcome of Patients with Acute Leukemia (AL): Myth or Reality?

Mael Heiblig, MD, Mohamed Elhamri, CRA, Véronique L'Héritier, Hélène Labussière-Wallet, MD, Fiorenza Barraco, MD, Sophie Ducastelle-Leprêtre, MD, Eric Wattel, MD PhD, Mauricette Michallet, MD PhD, Franck E Nicolini, MD PhD, Xavier Thomas, MD PhD

Blood (2014) 124 (21): 3679.

https://doi.org/10.1182/blood.V124.21.3679.3679

Published: 2014

Journal Articles

Hyperhomocysteinemia and High Doses of Nilotinib Favour Cardio-Vascular Events in Chronic Phase Chronic Myelogenous Leukemia (CML) Patients

Gaelle Fossard, MD, Emilie Blond, Pharm.D, Stephane Giraudier, MD PhD, Stephane Morisset, Stat., Jeremy Ruby, CRA student, Martine Escoffre-Barbe, MD, Hélène Labussière-Wallet, MD, Mael Heiblig, MD, Madeleine Etienne, CRA, Jocelyne Drai, Pharm.D, Mohamad Sobh, Pharm.M., Mauricette Michallet, MD PhD, Isabelle Redonnet-vernhet, MD PhD, Jean-christophe Lega, MD PhD, Gabriel Etienne, MD PhD, Franck E. Nicolini, MD PhD

Blood (2014) 124 (21): 3136.

https://doi.org/10.1182/blood.V124.21.3136.3136

Published: 2014

NARROW

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Therapy-Related Myeloid Neoplasm: A Study from the Chronic Malignancies Working Party of the EBMT

Allogeneic Hematopoietic Stem-Cell Transplantation for Patients with Richter's Syndrome:the SFGM-TC Experience

Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients with Acute Myeloid Leukemia: Analysis of the Francophone Society for Stem Cell Transplantation and Cell Therapy

The Impact of Cytogenetics on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia: A Survey from the Acute Leukemia Working Party (ALWP) of EBMT

Long-Term Outcome of Patients Receiving Extracorporeal Photopheresis for Acute and Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies: Results from an Observational Study on 106 Patients

Impact of Body Mass Index on Outcome in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Imatinib in First-Line

A Composite Event-Free Survival End Point to Evaluate Outcome after Allogeneic Transplantation for Severe Aplastic Anemia: A Study on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Reactive Hemophagocytic Syndrome after Hematopoietic Stem Cell Transplantation: A Multicenter Retrospective Study on Behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

First Results of a Prospective Study on Erythropoietin Biosimilar (Epoetin zeta) Use in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Survey of Serum Aspergillus Antigen in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia or Allogeneic Hematopoietic Stem Cell Transplantation: Role in Predicting Invasive Aspergillosis and in Modifying the Therapeutic Strategy

Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Peripheral Blood or Bone Marrow Donors: The Impact of HLA Matching Including HLA-DPB1 Allele in a Multivariable Risk Model

Optimizing the Outcomes of Allogeneic Hematopoietic Stem Cell (HSC) Transplantation for Hematological Malignancies: The Perfect Combination of Conditioning Regimen, Disease Stage and Type of HSC Donor

Brentuximab Vedotin Followed By Allogeneic Stem-Cell Transplantation for Patients with CD30 Anaplastic or T Cell Non Hodgkin Lymphomas: A Study on Behalf of the SFGM-TC.

Mixed Chimerism at Three Months after Allogeneic Hematopoietic Stem Cell Transplantation Is a Significant Predictor of Disease Relapse in High-Risk Acute Myeloid Leukemia Patients in First Complete Remission

Very Long-Term Follow-up (> 80 months) of Imatinib (IM) First-Line for Chronic Phase (CP) CML Patients

Primary Failure of Platelet Recovery Is the Foremost Prognostic Factor after Allogeneic Stem Cell Transplantation Following Myeloablative Conditioning for Myelodysplastic Syndrome: A Study from the SFGM-TC

Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients in First Complete Remission: Significant Impact of the Interval Between Diagnosis and Transplantation on Different Outcomes

Impact of Early Post-Transplant Complications on Survival of Patients with Myelodysplastic Syndrome Undergoing Allo-SCT Following Reduced Intensity Conditioning: An SFGM-TC Study

Impact of Initial Body Mass Index (BMI) on Survival Outcome of Patients with Acute Leukemia (AL): Myth or Reality?

Hyperhomocysteinemia and High Doses of Nilotinib Favour Cardio-Vascular Events in Chronic Phase Chronic Myelogenous Leukemia (CML) Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only